Clinical outcomes of tricuspid transcatheter edge-to-edge repair in patients with tricuspid regurgitation

1

Tricuspid transcatheter edge-to-edge repair (T-TEER) significantly reduces all-cause mortality in patients with tricuspid regurgitation (TR) compared to medical therapy.
2

At 1 year, T-TEER is associated with lower risks of heart failure exacerbation, hospitalization, emergency visits, and major adverse kidney events.
3

The benefits of T-TEER in reducing mortality and adverse outcomes persist at 3 and 5 years post-procedure.
4

This study utilized a large real-world cohort from the TriNetX health research network to compare T-TEER and medical management outcomes.
5

Findings support the prognostic advantage of T-TEER for patients with TR, highlighting its role in early intervention before irreversible damage.

Frontiers In Medicine

1